The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose-escalation study of IPH2102 (lirilumab, BMS-986015, LIRI), a fully human anti KIR monoclonal antibody (mAb) in patients (pts) with various hematologic (HEM) or solid malignancies (SOL).
 
Norbert Vey
No Relationships to Disclose
 
Anthony Goncalves
No Relationships to Disclose
 
Lionel Karlin
No Relationships to Disclose
 
Sophie Lebouvier-Sadot
No Relationships to Disclose
 
Florence Broussais
No Relationships to Disclose
 
Delphine Marie
Employment - Innate Pharma
Stock and Other Ownership Interests - Innate Pharma
Travel, Accommodations, Expenses - Innate Pharma
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Pascale Andre
Employment - Innate Pharma
Stock and Other Ownership Interests - Innate Pharma
Travel, Accommodations, Expenses - Innate Pharma
 
Robert Albert Zerbib
Employment - Innate Pharma
Stock and Other Ownership Interests - Innate Pharma
Travel, Accommodations, Expenses - Innate Pharma
 
Renaud Buffet
Employment - Innate Pharma
Stock and Other Ownership Interests - Innate Pharma
Travel, Accommodations, Expenses - Innate Pharma
 
Thomas Prébet
No Relationships to Disclose
 
Aude Charbonnier
No Relationships to Disclose
 
Jerome Rey
No Relationships to Disclose
 
Arnaud Pigneux
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Nicolas Boissel
No Relationships to Disclose
 
Gilles A. Salles
Honoraria - Amgen; Mundipharma; Roche/Genentech; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech